FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


CIT Leads $135.6MM Financing for Superior Biologics

December 02, 2022, 07:00 AM
Filed Under: Biotechnology

CIT, a division of First Citizens Bank, announced that its Healthcare Finance business served as lead arranger of $135.6 million in financing for Superior Biologics Inc.

Headquartered in Sharon Hill, Pennsylvania, Superior Biologics is a leading provider of specialty pharmacy and home infusion therapy services to patients contending with a wide variety of chronic illnesses. It currently operates seven accredited pharmacies across the U.S., serving patients in 43 states and having the capability to dispense medications in all 50 states.

The financing, which consists of a term loan and a revolving line of credit, will be used to refinance existing debt, fund a shareholder dividend, provide working capital and support growth initiatives.

“Our innovative and cost-effective pharmacy and in-home nursing infusion services help lead to optimal therapeutic outcomes and best-in-class patient results,” said Ray Mirra, founder and CEO of Superior Biologics. “We appreciated CIT’s agility and expertise in arranging financing that supports our business objectives.”

“We were pleased to again support Superior Biologics with another financing package tailored to advance their business goals,” said William Douglass, managing director and group head for CIT’s Healthcare Finance business.

“We always work closely with Superior Biologics to understand their needs,” said David Gibbs, a managing director in Healthcare Finance. “It is a pleasure to work with smart and successful companies and we look forward to continuing our association in the future.”

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.